Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease.
Fabry disease (FD) is an X-linked hereditary defect of glycosphingolipid storage caused by mutations in the gene encoding the lysosomal hydrolase α-galactosidase A (GLA, α-gal A). To date, over 400 mutations causing amino acid substitutions have been described. Most of these mutations are related to...
Main Authors: | Jan Lukas, Anne-Katrin Giese, Arseni Markoff, Ulrike Grittner, Ed Kolodny, Hermann Mascher, Karl J Lackner, Wolfgang Meyer, Phillip Wree, Viatcheslav Saviouk, Arndt Rolfs |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC3731228?pdf=render |
Similar Items
-
Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?
by: Tobias Böttcher, et al.
Published: (2013-01-01) -
Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients.
by: Arndt Rolfs, et al.
Published: (2013-01-01) -
Optimizing human α-galactosidase for treatment of Fabry disease
by: William C. Hallows, et al.
Published: (2023-03-01) -
Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease.
by: Lukas Hofmann, et al.
Published: (2017-01-01) -
Misfolding of Lysosomal α-Galactosidase a in a Fly Model and Its Alleviation by the Pharmacological Chaperone Migalastat
by: Hila Braunstein, et al.
Published: (2020-10-01)